Cargando…
Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
BACKGROUND: Warfarin is evidence-based therapy for the prevention of cardioembolic stroke, but has not been studied for its effects on whole blood viscosity (WBV). This study investigated the effect of warfarin versus aspirin on WBV in patients presenting with non-valvular atrial fibrillation (NVAF)...
Autores principales: | Lee, Chan-Hyuk, Jung, Keun-Hwa, Cho, Daniel J., Jeong, Seul-Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495650/ https://www.ncbi.nlm.nih.gov/pubmed/31043158 http://dx.doi.org/10.1186/s12883-019-1315-5 |
Ejemplares similares
-
The efficacy and safety of Hirudin plus Aspirin versus Warfarin in the secondary prevention of Cardioembolic Stroke due to Nonvalvular Atrial Fibrillation: A multicenter prospective cohort study
por: Song, Chang-geng, et al.
Publicado: (2021) -
The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation
por: Jung, Yo-Han, et al.
Publicado: (2023) -
Non-cardioembolic risk factors in atrial fibrillation-associated ischemic stroke
por: Yang, Pil-Sung, et al.
Publicado: (2018) -
Determinants of Visceral Infarction in Acute Cardioembolic Stroke Due to Atrial Fibrillation
por: Sohn, Sung-Il, et al.
Publicado: (2021) -
Sepsis as an independent risk factor in atrial fibrillation and cardioembolic stroke
por: Leng, Yiming, et al.
Publicado: (2023)